435 results on '"Jiang, Yi‐Zhou"'
Search Results
2. Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
3. Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation
4. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection
5. Advances in targeting histone deacetylase for treatment of solid tumors
6. Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy
7. Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
8. DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance
9. Molecular classification of hormone receptor-positive HER2-negative breast cancer
10. Radiomics in breast cancer: Current advances and future directions
11. Vitamin drinks improve palatability and reduce adverse events associated to polyethylene glycol electrolyte solutions
12. Targeting transposable elements in cancer: developments and opportunities
13. Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancer
14. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
15. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
16. Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
17. Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
18. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches
19. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
20. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
21. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
22. Emerging therapies in cancer metabolism
23. A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
24. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
25. Modeling of novel RF AlGaN/GaN HEMTs with the structure of n-Si drain extension
26. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
27. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target
28. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
29. Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review
30. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
31. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
32. Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
33. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
34. A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
35. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
36. Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
37. Domino hepatocyte transplantation using explanted human livers with metabolic defects attenuates D-GalN/LPS-induced acute liver failure
38. N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis
39. Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
40. Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens
41. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
42. Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis
43. ASO Visual Abstract: A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
44. ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study
45. 333.10: The Role of Immunosuppression Level in Liver Allograft Fibrosis After Pediatric Liver Transplantation
46. 211.13: No Difference in Posttransplant Survival Among Patients With or Without Nonalcoholic Steatohepatitis: A Meta-analysis and Meta-regression
47. Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor
48. Triple-negative breast cancer: new treatment strategies in the era of precision medicine
49. Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
50. Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.